Sign in

CIK 0001818794

  • Large accelerated filer

Dyne Therapeutics, Inc.

Sign in to watch
Ticker
DYN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
364883909
Phone
+1 781-786-8230
Business address
1560 TRAPELO ROAD, WALTHAM, MA, 02451
Open-market buys, last 90 days
$40,000
in 1 filing
Open-market sales, last 90 days
$421,679
in 7 filings, $422K under 10b5-1 plans

Net −$381,679. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-06-05 HURWITZ EDWARD Director Grant or award · Stock option (right to buy) +35,152 35,152
2025-05-30 HURWITZ EDWARD Director Grant or award · Stock option (right to buy) +35,000 35,000
2024-05-22 HURWITZ EDWARD Director Grant or award · Stock option (right to buy) +25,133 25,133
2023-05-24 HURWITZ EDWARD Director Grant or award · Stock Option (right to buy) +24,900 24,900
2022-06-03 HURWITZ EDWARD Director Grant or award · Stock Option (right to buy) +19,596 19,596
2021-05-26 HURWITZ EDWARD Director Grant or award · Stock Option (right to buy) +19,596 19,596
2020-09-21 HURWITZ EDWARD Director Conversion +4,614,943 4,614,943
2020-09-21 HURWITZ EDWARD Director Conversion +245,279 245,279
2020-09-21 HURWITZ EDWARD Director Conversion +91,081 91,081
2020-09-21 HURWITZ EDWARD Director Conversion · Series A Preferred Stock −13,980,992 0
2020-09-21 HURWITZ EDWARD Director Conversion · Series A Preferred Stock −743,076 0
2020-09-21 HURWITZ EDWARD Director Conversion · Series A Preferred Stock −275,932 0
2020-09-21 HURWITZ EDWARD Director Conversion · Series B Preferred Stock −1,326,313 0
2020-09-21 HURWITZ EDWARD Director Conversion · Series B Preferred Stock −70,492 0
2020-09-21 HURWITZ EDWARD Director Conversion · Series B Preferred Stock −26,176 0
2020-08-07 HURWITZ EDWARD Director Purchase · Series B Preferred Stock +1,326,313 $2.81 $3.7M 1,326,313
2020-08-07 HURWITZ EDWARD Director Purchase · Series B Preferred Stock +70,492 $2.81 $198K 70,492
2020-08-07 HURWITZ EDWARD Director Purchase · Series B Preferred Stock +26,176 $2.81 $74K 26,176
2020-07-31 HURWITZ EDWARD Director Purchase · Series A Preferred Stock +4,893,347 $1.00 $4.9M 13,980,992
2020-07-31 HURWITZ EDWARD Director Purchase · Series A Preferred Stock +260,077 $1.00 $260K 743,076

Page 1 of 2 · 21 trades